Table: Fuji Pharmaceutical -2019/20 group results

Fuji Pharma

05/11/2020 07:30

Nov 5 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Sep 30, 2020    Sep 30, 2019   Sep 30, 2021     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           33.79           36.28          34.70         17.30    
               (-6.9 pct)      (-4.3 pct)     (+2.7 pct)    (+2.3 pct)  
  Operating        3.14            4.17           2.86          1.69    
               (-24.8 pct)     (-5.0 pct)     (-9.0 pct)    (-2.9 pct)  
  Recurring        2.98            4.17           2.81          1.66    
               (-28.4 pct)     (-6.8 pct)     (-5.9 pct)    (+3.0 pct)  
  Net
  Net              2.09            2.96           2.10          1.30    
               (-29.6 pct)     (-12.2 pct)    (+0.7 pct)   (+318.8 pct) 
  EPS           66.94 yen       97.04 yen      67.40 yen     41.78 yen  
  Ann Div       29.00 yen       29.00 yen      29.00 yen                
  -Q2 Div       14.00 yen       14.00 yen      14.00 yen                
  -Q4 Div       15.00 yen       15.00 yen      15.00 yen                
  
  NOTE - Fuji Pharmaceutical  Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T